Table 1.

Characteristics of the study population

Characteristics	N	%	Citation
Mean age	33, 7	–	[19–37]
Sex
Male	276,751	66,9	[19–36, 38–40]
Female	137,025	33,1	[19–36, 38–40]
Type of DR TB
RR/ MDR	2173	0,5	[19–35, 38, 39]
PRE- XDR	104	0, 03	[19–35, 38, 39]
XDR	330	0,08	[19–35, 38, 39]
Mono drug resistance (other than RIF)	136	0,03	[19–35, 38, 39]
Poli drug resistance)	18	0,004	[19–35, 38, 39]
STB/ controls	2473	0,5	[19–35, 38, 39]
DRTB type not indicated (no breakdown)	408,542	98,7	[36, 37, 40]
Duration of study – Average duration of studies	32 months	–	[19–40]
Treatment outcomes
Favourable (Cured/ Treatment completed)	89,410	21,60	[29, 31, 33, 37]
Unfavourable (Died/ Defaulted/ LTFU/ Failed/ relapse)	66,063	15, 96	[29, 31, 33, 37]
Transferred out	8	0,002	[31]
Treatment outcome not evaluated in study	258,295	62,42	[30, 32, 34–36, 38–40]